Cost-Effectiveness Analysis of Chemoprophylaxis of Malaria Treatment

Malaria is an infectious disease in developing and underdeveloped countries that is a major threat to health. It is known to be transmitted through female mosquitoes to female parasites1. In Korea, there is a Vivax malaria virus in the vicinity of the ceasefire line. In this case, the fever that gradually increases with the feeling of boredom lasts for several days in the early days, and chills, fever and fever after repeated fever may accompany headache, nausea, and diarrhea7. In the case of vivax malaria, the annual number of patients increased from the first patient in 1993 to more than 4,000 in 2000. It is a mosquito-borne infectious disease originating from North Korea, mainly caused by soldiers working near the armistice. It then declined rapidly to 800 in 20043. However, since 2005, it has increased again, and since 2006, more than 2,000 patients have occurred each year. As of 2015, there are about 600 cases per year6,7.